Elisabeth Possnecker
Overview
Explore the profile of Elisabeth Possnecker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuo M, Fettig N, Bernier L, Possnecker E, Spring S, Pu A, et al.
JCI Insight
. 2024 Jun;
9(12).
PMID: 38912582
No abstract available.
2.
Wang A, Luessi F, Neziraj T, Possnecker E, Zuo M, Engel S, et al.
Sci Transl Med
. 2024 Mar;
16(737):eadi0295.
PMID: 38446903
Anti-CD20 therapy to deplete B cells is highly efficacious in preventing new white matter lesions in patients with relapsing-remitting multiple sclerosis (RRMS), but its protective capacity against gray matter injury...
3.
Neziraj T, Siewert L, Possnecker E, Probstel A
Eur J Immunol
. 2023 Aug;
53(11):e2250033.
PMID: 37624875
Regulatory B cells (Bregs) are immunosuppressive cells that support immunological tolerance by the production of IL-10, IL-35, and TGF-β. Bregs arise from different developmental stages in response to inflammatory stimuli....
4.
Diebold M, Meola M, Purushothaman S, Siewert L, Possnecker E, Roloff T, et al.
Gut Microbes
. 2022 Nov;
14(1):2147055.
PMID: 36398902
Mounting evidence points towards a pivotal role of gut microbiota in multiple sclerosis (MS) pathophysiology. Yet, whether disease-modifying treatments alter microbiota composition and whether microbiota shape treatment response and side-effects...
5.
Etter M, Martins T, Kulsvehagen L, Possnecker E, Duchemin W, Hogan S, et al.
Nat Commun
. 2022 Nov;
13(1):6777.
PMID: 36351919
Growing evidence links COVID-19 with acute and long-term neurological dysfunction. However, the pathophysiological mechanisms resulting in central nervous system involvement remain unclear, posing both diagnostic and therapeutic challenges. Here we...
6.
Zuo M, Fettig N, Bernier L, Possnecker E, Spring S, Pu A, et al.
JCI Insight
. 2022 May;
7(12).
PMID: 35536649
People living with multiple sclerosis (MS) experience episodic CNS white matter lesions instigated by autoreactive T cells. With age, patients with MS show evidence of gray matter demyelination and experience...